Join our Mailing list!
Join our newsletter for the latest updates, insights, and exclusive offers on everything psychedelic therapy.
Join ATMA Co-founders David Harder and Vu Tran for an information session detailing the road map to get psilocybin and MDMA through clinical trials and on to a designation for therapy use in Canada and the United States. We will discuss how recent regulations in Alberta, Canada, as well as Oregon legalization and Colorado legal pathway in the US fits into the road map for legal psychedelic-assisted therapy regulations.
Wherever you practice in North America, if you are interested in psychedelic assisted therapy, you will benefit from the information and discussion with mental healthcare professionals on this subject. You’ll be surprised to learn that integrating psychedelic-assisted therapy into your practice is possible sooner than you think!
What you’ll learn: